Yoshiaki Omura
New York Medical College, USA
Title: Clinical application of 8 unique beneficial effects of individually determined optimal dose of vitamin D3 for safe, effective treatment of cancer as well as prevention of possible cancer infection due to mixed infection of human Papilloma virus - type 16 (HPV-16) & intracellular single cell parasite Toxoplasma Gondii as a potential source of cancer spread
Biography
Biography: Yoshiaki Omura
Abstract
Our previous study indicated that individually determined optimal dose of Vitamin D3 has following 8 unique, beneficial effects: 1) significant Anti-cancer effects without side effects; 2) marked decrease in DNA mutation which is proportional to the decrease in 8-OH-dG; 3) marked urinary excretion of Viruses, Bacteria, Fungi, single-cell parasites, & Toxic substances, including Asbestos & metals such as Hg, Pb, & Al; 4) marked increase in Acetylcholine in the brain & the rest of the body; 5) marked increase in DHEA; 6) marked decrease in β-Amyloid (1-42) in brain; 7) marked decrease in Cardiac Troponin I, and 8) anti-allergic effects. Also, our study indicated that average optimal dose of healthy adult is anywhere between 300-500 I.U. In the presence of the early stage of the malignancy, the optimal dose of Vitamin D3 increases to anywhere between 600-1200 I.U. when cancer is advanced it can go up to maximum of 3000 I. U. or even higher. Its anti-cancer effects are often far superior to the many standard cancer treatments without any side effects. One optimal dose usually lasts average of 8 hours. Therefore, optimal dose has to be taken 3 times a day in order to maintain beneficial effects of Vitamin D3. In addition, our recent study indicates that significant infection of Human Papilloma Virus - Type 16 (=HPV-16) co-exists together with intracellular, single-cell infection of Toxoplasma Gondii, high incidence of the malignancies was found in the infected areas. We also found when cancer advances, optimal dose of Vitamin D3 increases and when the cancer improves, optimal dose of Vitamin D3 also reduces. Therefore, non-invasive measurement of individualized optimal dose of Vitamin D3 become very important clinically. We also found family members living with cancer patients everyday in the same home and often talk in short distance in the same room, most of the family members are also infected to the same degree of the mixed infection as the cancer patients. At low level of infection, incidence of malignancy is also low. Use of optimal dose of Vitamin D3 also significantly lowers these mixed infections because one of the unique beneficial effects of Vitamin D3 is significant urinary excretion of microorganisms. Thus, taking optimal dose of Vitamin D3, even in advanced cancer patient not only inhibits cancer activity but also significantly reduces potential contributing factors of these infections. Also, for family members or nurses who have frequent daily contact with advanced cancer patients, it is highly advisable to take optimal dose of Vitamin D3 to prevent future cancer developments. However, our study indicates that beneficial effects of optimal dose of Vitamin D3 will be completely inhibited by taking overdose of Vitamin C originally promoted by Nobel Prize Winner Professor Linus Pauling.